SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0000950123-01-502019
Filing Date
2001-05-08
Accepted
2001-05-08 00:00:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 POST EFFECTIVE AMENDMENT NO. 1 m09941pposam.txt POS AM 317996
2 CONSENT OF KPMG m09941pex23-1.txt EX-23.1 773
  Complete submission text file 0000950123-01-502019.txt   320358
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT, QUEBEC CANADA, H4M 2V2 A8
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT, QUEBEC CANADA H4M 2V2 A8 514-332-3222
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-31310 | Film No.: 1625485
SIC: 2835 In Vitro & In Vivo Diagnostic Substances